IDENIX PHARM
Norcod AS engages in the farming, production, operation, distribution, marketing, and sale of farmed cod products in Norway and internationally. The company was incorporated in 2018 and is headquartered in Trondheim, Norway.
Market Cap & Net Worth: IDENIX PHARM (NO9)
IDENIX PHARM (MU:NO9) has a market capitalization of $62.66 Million (€61.04 Million) as of March 18, 2026. Listed on the MU stock exchange, this Germany-based company holds position #24510 globally and #2677 in its home market, demonstrating a -13.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IDENIX PHARM's stock price €0.87 by its total outstanding shares 70328227 (70.33 Million).
IDENIX PHARM Market Cap History: 2022 to 2026
IDENIX PHARM's market capitalization history from 2022 to 2026. Data shows change from $386.98 Million to $62.66 Million (-42.63% CAGR).
IDENIX PHARM Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IDENIX PHARM's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.20x
IDENIX PHARM's market cap is 0.20 times its annual revenue
0.16x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $386.98 Million | $170.54 Million | -$297.22 Million | 2.27x | N/A |
| 2023 | $93.85 Million | $269.42 Million | -$246.18 Million | 0.35x | N/A |
| 2024 | $77.97 Million | $397.18 Million | -$235.00 Million | 0.20x | N/A |
Competitor Companies of NO9 by Market Capitalization
Companies near IDENIX PHARM in the global market cap rankings as of March 18, 2026.
Key companies related to IDENIX PHARM by market ranking:
- Archer-Daniels-Midland Company (NYSE:ADM): Ranked #619 globally with a market cap of $33.40 Billion USD.
- Bunge Limited (NYSE:BG): Ranked #996 globally with a market cap of $19.69 Billion USD.
- Tyson Foods Inc (NYSE:TSN): Ranked #1128 globally with a market cap of $17.05 Billion USD.
- Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #1198 globally with a market cap of $15.65 Billion USD ( CN¥114.85 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #619 | Archer-Daniels-Midland Company | NYSE:ADM | $33.40 Billion | $70.75 |
| #996 | Bunge Limited | NYSE:BG | $19.69 Billion | $123.62 |
| #1128 | Tyson Foods Inc | NYSE:TSN | $17.05 Billion | $61.83 |
| #1198 | Muyuan Foodstuff Co Ltd | SHE:002714 | $15.65 Billion | CN¥49.74 |
IDENIX PHARM Historical Marketcap From 2022 to 2026
Between 2022 and today, IDENIX PHARM's market cap moved from $386.98 Million to $ 62.66 Million, with a yearly change of -42.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €62.66 Million | -17.73% |
| 2025 | €76.16 Million | -2.31% |
| 2024 | €77.97 Million | -16.92% |
| 2023 | €93.85 Million | -75.75% |
| 2022 | €386.98 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of IDENIX PHARM was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $62.66 Million USD |
| MoneyControl | $62.66 Million USD |
| MarketWatch | $62.66 Million USD |
| marketcap.company | $62.66 Million USD |
| Reuters | $62.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.